<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-128927</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">No disponible</dc:description>
<dc:creator>Yu, Cheuk-Man</dc:creator>
<dc:creator>Fang, Fang</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Rev Esp Cardiol;67(11): 875-877, nov. 2014. tab</dc:source>
<dc:identifier>ibc-128927</dc:identifier>
<dc:title xml:lang="es">¿La terapia de resincronización cardiaca con desfibrilador se debe reducir a otra con marcapasos para los superrespondedores?</dc:title>
<dc:subject>^d29633</dc:subject>
<dc:subject>^d54223^s22074</dc:subject>
<dc:subject>^d21027^s22074</dc:subject>
<dc:subject>^d1150^s22067</dc:subject>
<dc:subject>^d15100^s22067</dc:subject>
<dc:subject>^d10326^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:type>article</dc:type>
<dc:date>201411</dc:date>
</metadata>
</record>
</ibecs-document>
